Skip to content

Assessment of effect of steam inhalation, saline gargling and povidone Iodine gargling on reduction of symptoms and prevention of spread of COVID 19

â??Impact of steam inhalation, saline gargling and povidone Iodine gargling on clinical outcome of COVID-19 patients under home isolation in Bengaluru, Karnataka â?? a Randomised Control Trialâ??â?? (SISPIG study) - SISPIG

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027687
Enrollment
80
Registered
2020-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J128- Other viral pneumonia

Interventions

Intervention1: Steam inhalation,saline gargling,povidine iodine gargling,one more is control group for whom no intervention is applied: 1. Saline gargling: Hypertonic saline solution is prepared by ad

Sponsors

Dr Shobha
Lead Sponsor
BBMP bengaluru
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: I. All patients with age more than 18 years who are asymptomatic,mild cases of COVID-19 who are under home isolation II. COVID-19 positive cases under home isolation who consents for the study III. Household contacts of home isolated COVID-19 patients who are able to understand and follow/perform the interventions.

Exclusion criteria

Exclusion criteria: i. Patients with known history of immuno-suppressive disorders ii. Patients with known history of hyperthyroidism and other thyroid diseases and with symptoms suggestive of thyroid dysfunction like tremors, palpitation, heat/cold intolerance, lethargy, menstrual irregularities etc iii. Pregnant and lactating women iv. Patients with nasal polyps, recurrent nasal bleeding v. Patients with known allergy to iodine and its compounds and on Lithium therapy

Design outcomes

Primary

MeasureTime frame
1) Reduction in severity of symptoms (VAS, temperature etc) in mild cases 2) Early negativity of the RT PCR in nasopharyngeal swab among the intervention group when compared to the controls 3) Reduction in transmission of infection among household members of COVID-19 patient Timepoint: 1) Baseline assessment and daily follow up of symptoms till 21 days 2) Baseline swab test and swab test once every 3 days till two successive tests are negative 3) Baseline symptomatic assessment of contacts and daily follow up of evolution of symptoms till 21 days and one swab test between 5th to 10th days of contact to assess transmission pattern.

Secondary

MeasureTime frame
Reduction in transmission of infection among household members of COVID-19 patient Timepoint: 21 days

Countries

India

Contacts

Public ContactDr shobha

Bangalore medical college and Research institute

shobha_bhushan@yahoo.co.in9449637523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026